WHO ICTRP trial
Epigenetic changes as a cause of post-finasteride syndrome
DRKS00035509 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00035509 |
|---|---|
| Public title | Epigenetic changes as a cause of post-finasteride syndrome |
| Scientific title | Epigenetic changes as a cause of post-finasteride syndrome |
| Primary sponsor | Institut für Humangenetik |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Germany |
| Conditions | R53 R41.3 F52.8 F52.0 M62.5;Malaise and fatigue;Other amnesia;Other sexual dysfunction, not caused by organic disorder or disease;Lack or loss of sexual desire;Muscle wasting and atrophy, not elsewhere classified |
| Interventions | Group 1: 12 PFS subjects At the time of patient presentation: Medical history and physical examination are performed, including the collection of demographic data such as age, weight, and height. Additionally, questionnaires are… |
| Registration date | Nov 8, 2025 |
| Target size | 24 |
| Secondary IDs | D 584/22 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: